GlassScriptPhysician profile
James S Mcbride
NPI 1700856267
$3,703.01
in general payments reported to CMS, 2019-2025
20 companies · $625 in 2025
The $625 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2020: $339 · 2021: $498 · 2022: $497 · 2023: $687 · 2024: $680 · 2025: $625.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,992.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,992.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,065.02 | 2019-2025 | Total30, Precision7, Tryptyr |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $366.42 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $291.33 | 2022-2025 | Miebo, Infuse, Xiidra |
| Coopervision INC. | $233.63 | 2021-2023 | Misight Contact Lens |
| Oyster Point Pharma, INC. | $228.83 | 2022-2025 | Tyrvaya, Ryzumvi |
| Aerie Pharmaceuticals, INC. | $207.15 | 2019-2021 | |
| Allergan, INC. | $195.61 | 2019-2022 | |
| Dompe US, INC. | $187.34 | 2023-2025 | Oxervate |
| Glaukos Corporation | $164.80 | 2023 | |
| Johnson & Johnson Vision Care, INC. | $141.55 | 2023-2024 | Acuvue |
| Novartis Pharmaceuticals Corporation | $137.77 | 2019-2022 | |
| Biotissue Holdings INC. | $135.11 | 2022-2024 | |
| Sun Pharmaceutical Industries INC. | $104.77 | 2021-2025 | |
| Astellas Pharma US INC | $70.90 | 2024-2025 | Izervay |
| Abbvie INC. | $50.07 | 2022-2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $48.99 | 2024-2025 | Xdemvy |
| Eyevance Pharmaceuticals LLC | $20.66 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Thea Pharma INC. | $17.63 | 2024 | Iyuzeh |
| Integra Lifesciences Corporation | $16.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mcbride listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.